FALZONE, YURI MATTEO
 Distribuzione geografica
Continente #
EU - Europa 170
NA - Nord America 132
AS - Asia 42
AF - Africa 1
SA - Sud America 1
Totale 346
Nazione #
US - Stati Uniti d'America 132
SE - Svezia 74
IT - Italia 72
CN - Cina 26
DE - Germania 7
GB - Regno Unito 7
JP - Giappone 5
SG - Singapore 5
CH - Svizzera 3
IE - Irlanda 2
IR - Iran 2
TR - Turchia 2
AR - Argentina 1
ES - Italia 1
FI - Finlandia 1
FR - Francia 1
GR - Grecia 1
KH - Cambogia 1
NG - Nigeria 1
PT - Portogallo 1
TW - Taiwan 1
Totale 346
Città #
New York 20
Shanghai 20
Milan 18
Ashburn 17
Lawrence 14
Princeton 14
Rome 8
Los Angeles 5
Grosseto 4
London 3
San Fermo della Battaglia 3
San Mateo 3
Sesto San Giovanni 3
Asti 2
Dartford 2
Dublin 2
Fremont 2
Gallarate 2
Hiro-oshingai 2
Novara 2
Parma 2
Salerno 2
Tehran 2
Travagliato 2
Zurich 2
Agrinio 1
Barcelona 1
Boston 1
Brugherio 1
Cagliari 1
Carcavelos 1
Córdoba 1
Edinburgh 1
Frankfurt am Main 1
Genoa 1
Hanover 1
Helsinki 1
Iowa City 1
Kayseri 1
Kumamoto 1
Limbiate 1
Samaru 1
Sapporo 1
Seattle 1
Sheffield 1
Sivas 1
Tulare 1
Vercelli 1
Washington 1
Winterberg 1
Yokohama 1
Totale 182
Nome #
Peripheral Nervous System Involvement in Amyotrophic Lateral Sclerosis: from diagnosis to disease understanding and development of novel biomarkers 98
Primary Lateral Sclerosis Presenting With Focal Onset Spreading Through Contiguous Neuroanatomic Regions 23
Neurofilament light chain as a biological marker for amyotrophic lateral sclerosis: a meta-analysis study 19
Painful legs and moving toes syndrome: treating movement to treat pain—a case report 18
Eculizumab as a fast-acting rescue therapy in a refractory myasthenic crisis: a case report 17
Post-infectious Guillain–Barré syndrome related to SARS-CoV-2 infection: a case report 17
Serum phosphorylated neurofilament heavy-chain levels reflect phenotypic heterogeneity and are an independent predictor of survival in motor neuron disease 16
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 16
Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial 15
Burden of rare variants in ALS and axonal hereditary neuropathy genes influence survival in ALS: Insights from a next generation sequencing study of an Italian ALS cohort 15
Structural and functional brain connectome in motor neuron diseases: A multicenter MRI study 15
Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives 15
Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis 15
Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis 15
Going for a stroll on lurasidone: Considerations on an atypical case of acute compartment syndrome of both legs 13
Clinical features and outcomes of the flail arm and flail leg and pure lower motor neuron MND variants: a multicentre Italian study 13
Clinical and pathological findings in neurolymphomatosis: Preliminary association with gene expression profiles in sural nerves 12
Unveiling the SOD1-mediated ALS phenotype: insights from a comprehensive meta-analysis 11
Evaluation of the combined effect of mobility and seasonality on the COVID-19 pandemic: a Lombardy-based study 7
Corrigendum to “Going for a stroll on lurasidone: Considerations on an atypical case of acute compartment syndrome of both legs” [Heliyon 9(4) (April 2023) e15047] (Heliyon (2023) 9(4), (S2405844023022545), (10.1016/j.heliyon.2023.e15047)) 6
Structural and Functional Brain Network Connectivity at Different King's Stages in Patients With Amyotrophic Lateral Sclerosis 4
Totale 380
Categoria #
all - tutte 3.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.768


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 5 0 1 2 0 0 2 0 0 0
2021/202234 0 0 0 8 0 2 2 1 2 2 14 3
2022/2023145 32 35 13 2 5 19 8 13 3 3 7 5
2023/2024190 7 26 19 23 12 31 17 29 4 14 8 0
Totale 380